These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 25776081)

  • 1. Cytomegalovirus immune evasion of myeloid lineage cells.
    Brinkmann MM; Dağ F; Hengel H; Messerle M; Kalinke U; Čičin-Šain L
    Med Microbiol Immunol; 2015 Jun; 204(3):367-82. PubMed ID: 25776081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Interplay between Human Cytomegalovirus and Pathogen Recognition Receptor Signaling.
    Marques M; Ferreira AR; Ribeiro D
    Viruses; 2018 Sep; 10(10):. PubMed ID: 30241345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The early monocytic response to cytomegalovirus infection is MyD88 dependent but occurs independently of common inflammatory cytokine signals.
    Wikstrom ME; Khong A; Fleming P; Kuns R; Hertzog PJ; Frazer IH; Andoniou CE; Hill GR; Degli-Esposti MA
    Eur J Immunol; 2014 Feb; 44(2):409-19. PubMed ID: 24166710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prominent Role of the Human Cytomegalovirus UL8 Glycoprotein in Restraining Proinflammatory Cytokine Production by Myeloid Cells at Late Times during Infection.
    Pérez-Carmona N; Martínez-Vicente P; Farré D; Gabaev I; Messerle M; Engel P; Angulo A
    J Virol; 2018 May; 92(9):. PubMed ID: 29467314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The battle between host antiviral innate immunity and immune evasion by cytomegalovirus.
    Li S; Xie Y; Yu C; Zheng C; Xu Z
    Cell Mol Life Sci; 2024 Aug; 81(1):341. PubMed ID: 39120730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.
    Gardner TJ; Tortorella D
    Microbiol Mol Biol Rev; 2016 Sep; 80(3):663-77. PubMed ID: 27307580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMV immune evasion and manipulation of the immune system with aging.
    Jackson SE; Redeker A; Arens R; van Baarle D; van den Berg SPH; Benedict CA; Čičin-Šain L; Hill AB; Wills MR
    Geroscience; 2017 Jun; 39(3):273-291. PubMed ID: 28647908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
    Rölle A; Olweus J
    APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FcγRIIa cross-talk with TLRs, IL-1R, and IFNγR selectively modulates cytokine production in human myeloid cells.
    Vogelpoel LT; Hansen IS; Visser MW; Nagelkerke SQ; Kuijpers TW; Kapsenberg ML; de Jong EC; den Dunnen J
    Immunobiology; 2015 Feb; 220(2):193-9. PubMed ID: 25108563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.
    El Baba R; Herbein G
    Front Immunol; 2021; 12():730765. PubMed ID: 34566995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The myeloid cytokine network in AIDS pathogenesis.
    Mir KD; Mavigner M; Silvestri G
    Cytokine Growth Factor Rev; 2012; 23(4-5):223-31. PubMed ID: 22748236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I Interferon Released by Myeloid Dendritic Cells Reversibly Impairs Cytomegalovirus Replication by Inhibiting Immediate Early Gene Expression.
    Holzki JK; Dağ F; Dekhtiarenko I; Rand U; Casalegno-Garduño R; Trittel S; May T; Riese P; Čičin-Šain L
    J Virol; 2015 Oct; 89(19):9886-95. PubMed ID: 26202227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models.
    Lemmermann NA; Böhm V; Holtappels R; Reddehase MJ
    Virus Res; 2011 May; 157(2):161-74. PubMed ID: 20933556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus (CMV) research in immune senescence comes of age: overview of the 6th International Workshop on CMV and Immunosenescence.
    Nikolich-Žugich J; van Lier RAW
    Geroscience; 2017 Jun; 39(3):245-249. PubMed ID: 28624867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the innate immune response by human cytomegalovirus.
    Biolatti M; Gugliesi F; Dell'Oste V; Landolfo S
    Infect Genet Evol; 2018 Oct; 64():105-114. PubMed ID: 29935337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMV and natural killer cells: shaping the response to vaccination.
    Goodier MR; Jonjić S; Riley EM; Juranić Lisnić V
    Eur J Immunol; 2018 Jan; 48(1):50-65. PubMed ID: 28960320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who's Driving? Human Cytomegalovirus, Interferon, and NFκB Signaling.
    Goodwin CM; Ciesla JH; Munger J
    Viruses; 2018 Aug; 10(9):. PubMed ID: 30134546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuning the Tumor Myeloid Microenvironment to Fight Cancer.
    Jahchan NS; Mujal AM; Pollack JL; Binnewies M; Sriram V; Reyno L; Krummel MF
    Front Immunol; 2019; 10():1611. PubMed ID: 31402908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion.
    Mocarski ES
    Trends Microbiol; 2002 Jul; 10(7):332-9. PubMed ID: 12110212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus tropism for mucosal myeloid dendritic cells.
    Hertel L
    Rev Med Virol; 2014 Nov; 24(6):379-95. PubMed ID: 24888709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.